BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Winkler MS, Skirecki T, Brunkhorst FM, Cajander S, Cavaillon JM, Ferrer R, Flohé SB, García-Salido A, Giamarellos-Bourboulis EJ, Girardis M, Kox M, Lachmann G, Martin-Loeches I, Netea MG, Spinetti T, Schefold JC, Torres A, Uhle F, Venet F, Weis S, Scherag A, Rubio I, Osuchowski MF. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge. EBioMedicine 2021;66:103291. [PMID: 33813139 DOI: 10.1016/j.ebiom.2021.103291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gruber AD, Firsching TC, Trimpert J, Dietert K. Hamster models of COVID-19 pneumonia reviewed: How human can they be? Vet Pathol 2021;:3009858211057197. [PMID: 34856819 DOI: 10.1177/03009858211057197] [Reference Citation Analysis]
2 Cavaillon J, Osuchowski MF. COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective. Journal of Intensive Medicine 2021;1:4-13. [DOI: 10.1016/j.jointm.2021.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
4 Ryu DK, Kang B, Noh H, Woo SJ, Lee MH, Nuijten PM, Kim JI, Seo JM, Kim C, Kim M, Yang E, Lim G, Kim SG, Eo SK, Choi JA, Song M, Oh SS, Chung HY, Tijsma AS, van Baalen CA, Kwon KS, Lee SY. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2. Biochem Biophys Res Commun 2021;578:91-6. [PMID: 34547629 DOI: 10.1016/j.bbrc.2021.09.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Da Costa CBP, Cruz ACM, Penha JCQ, Castro HC, Da Cunha LER, Ratcliffe NA, Cisne R, Martins FJ. Using in vivo animal models for studying SARS-CoV-2. Expert Opin Drug Discov 2021;:1-17. [PMID: 34727803 DOI: 10.1080/17460441.2022.1995352] [Reference Citation Analysis]
6 Choudhary S, Kanevsky I, Tomlinson L. Animal models for studying covid-19, prevention, and therapy: Pathology and disease phenotypes. Vet Pathol 2022;:3009858221092015. [PMID: 35451341 DOI: 10.1177/03009858221092015] [Reference Citation Analysis]
7 Vaka R, Khan S, Ye B, Risha Y, Parent S, Courtman D, Stewart DJ, Davis DR. Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury. Stem Cell Res Ther 2022;13:20. [PMID: 35033181 DOI: 10.1186/s13287-021-02699-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]